|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980-2011), with
predictions to 2015 and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Bray F, Pisani P and Parkin DM:
Globocan 2000: Cancer Incidence, Mortality and Prevalence
Worldwide. IARC Press; Lyon: 2001
|
|
3
|
Velho S, Fernandes MS, Leite M, Figueiredo
C and Seruca R: Causes and consequences of microsatellite
instability in gastric carcinogenesis. World J Gastroenterol.
20:16433–16442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oue N, Aung PP, Mitani Y, Kuniyasu H,
Nakayama H and Yasui W: Genes involved in invasion and metastasis
of gastric cancer identified by array-based hybridization and
serial analysis of gene expression. Oncology. 69 Suppl 1:S17–S22.
2005. View Article : Google Scholar
|
|
5
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ganesan K, Ivanova T, Wu Y, Rajasegaran V,
Wu J, Lee MH, Yu K, Rha SY, Chung HC, Ylstra B, et al: Inhibition
of gastric cancer invasion and metastasis by PLA2G2A, a novel
beta-catenin/TCF target gene. Cancer Res. 68:4277–4286. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dun B, Sharma A, Teng Y, Liu H, Purohit S,
Xu H, Zeng L and She JX: Mycophenolic acid inhibits migration and
invasion of gastric cancer cells via multiple molecular pathways.
PLoS One. 8:e817022013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Guo J, Wang Q, Zhou J, Xu C, Teng
R, Chen Y, Wei Q and Liu ZP: LZTFL1 suppresses gastric cancer cell
migration and invasion through regulating nuclear translocation of
β-catenin. J Cancer Res Clin Oncol. 140:1997–2008. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang
M, Wang CJ, Cao H and Xu J: HOTAIR long noncoding RNA promotes
gastric cancer metastasis through suppression of poly r(C)-binding
protein (PCBP) 1. Mol Cancer Ther. 14:1162–1170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu D, Nakano J, Ishikawa S, Yokomise H,
Ueno M, Kadota K, Urushihara M and Huang CL: Overexpression of
matrix metalloproteinase-7 (MMP-7) correlates with tumor
proliferation, and a poor prognosis in non-small cell lung cancer.
Lung Cancer. 58:384–391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kubben FJ, Sier CF, van Duijn W, Griffioen
G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB and
Verspaget HW: Matrix metalloproteinase-2 is a consistent prognostic
factor in gastric cancer. Br J Cancer. 94:1035–1040. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shim KN, Jung SA, Joo YH and Yoo K:
Clinical significance of tissue levels of matrix metalloproteinases
and tissue inhibitors of metalloproteinases in gastric cancer. J
Gastroenterol. 42:120–128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Łukaszewicz-Zając M, Mroczko B and
Szmitkowski M: Gastric cancer-The role of matrix metalloproteinases
in tumor progression. Clin Chim Acta. 412:1725–1730. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao ZS, Chu YQ, Ye ZY, Wang YY and Tao
HQ: Overexpression of matrix metalloproteinase 11 in human gastric
carcinoma and its clinicopathologic significance. Hum Pathol.
41:686–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kou YB, Zhang SY, Zhao BL, Ding R, Liu H
and Li S: Knockdown of MMP11 inhibits proliferation and invasion of
gastric cancer cells. Int J Immunopathol Pharmacol. 26:361–370.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stewart CE and Rotwein P: Growth,
differentiation, and survival: Multiple physiological functions for
insulin-like growth factors. Physiol Rev. 76:1005–1026. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
LeRoith D, Werner H, Beitner-Johnson D and
Roberts CT Jr: Molecular and cellular aspects of the insulin-like
growth factor I receptor. Endocr Rev. 16:143–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delafontaine P, Song YH and Li Y:
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1
binding proteins in blood vessels. Arterioscler Thromb Vasc Biol.
24:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Moerkens M, Ramaiahgari S, de
Bont H, Price L, Meerman J and van de Water B: Elevated
insulin-like growth factor 1 receptor signaling induces
antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling
routes. Breast Cancer Res. 13:R522011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang HJ, Yi YW, Kim HJ, Hong YB, Seong YS
and Bae I: BRCA1 negatively regulates IGF-1 expression through an
estrogen-responsive element-like site. Cell Death Dis. 3:e3362012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li S, Lei X, Zhang J, Yang H, Liu J and Xu
C: Insulin-like growth factor 1 promotes growth of gastric cancer
by inhibiting foxo1 nuclear retention. Tumour Biol. 36:4519–4523.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge J and Chen Z, Huang J, Yuan W, Den Z
and Chen Z: Silencing insulin-like growth factor-1 receptor
expression inhibits gastric cancer cell proliferation and invasion.
Mol Med Rep. 11:633–638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seoane A, Bessa X, Balleste B, O'Callaghan
E, Panadès A, Alameda F, Navarro S, Gallén M, Andreu M and Bory F:
Helicobacter pylori and gastric cancer: Relationship with
histological subtype and tumor location. Gastroenterol Hepatol.
28:60–64. 2005.(In Spanish). View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ajani J, D'Amico TA, Hayman JA, Meropol NJ
and Minsky B: National Comprehensive Cancer Network: Gastric
cancer. Clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 1:28–39. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsubara J, Yamada Y, Nakajima TE, Kato
K, Hamaguchi T, Shirao K, Shimada Y and Shimoda T: Clinical
significance of insulin-like growth factor type 1 receptor and
epidermal growth factor receptor in patients with advanced gastric
cancer. Oncology. 74:76–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim JE, Lee MH, Nam DH, Song HK, Kang YS,
Lee JE, Kim HW, Cha JJ, Hyun YY, Han SY, et al: Celastrol, an NF-κB
inhibitor, improves insulin resistance and attenuates renal injury
in db/db mice. PLoS One. 8:e620682013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vignais ML, Sadowski HB, Watling D, Rogers
NC and Gilman M: Platelet-derived growth factor induces
phosphorylation of multiple JAK family kinases and STAT proteins.
Mol Cell Biol. 16:1759–1769. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giorgetti-Peraldi S, Peyrade F, Baron V
and Van Obberghen E: Involvement of Janus kinases in the insulin
signaling pathway. Eur J Biochem. 234:656–660. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saad MJ, Carvalho CR, Thirone AC and
Velloso LA: Insulin induces tyrosine phosphorylation of JAK2 in
insulin-sensitive tissues of the intact rat. J Biol Chem.
271:22100–22104. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gual P, Baron V, Lequoy V and Van
Obberghen E: Interaction of Janus kinases JAK-1 and JAK-2 with the
insulin receptor and the insulin-like growth factor-1 receptor.
Endocrinology. 139:884–893. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen J, Sadowski HB, Kohanski RA and Wang
LH: Stat5 is a physiological substrate of the insulin receptor.
Proc Natl Acad Sci USA. 94:2295–2300. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sawka-Verhelle D, Filloux C,
Tartare-Deckert S, Mothe I and Van Obberghen E: Identification of
Stat 5B as a substrate of the insulin receptor. Eur J Biochem.
250:411–417. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yadav A, Kalita A, Dhillon S and Banerjee
K: JAK/STAT3 pathway is involved in survival of neurons in response
to insulin-like growth factor and negatively regulated by
suppressor of cytokine signaling-3. J Biol Chem. 280:31830–31840.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sanchez-Lopez E, Flashner-Abramson E,
Shalapour S, Zhong Z, Taniguchi K, Levitzki A and Karin M:
Targeting colorectal cancer via its microenvironment by inhibiting
IGF-1 receptor-insulin receptor substrate and STAT3 signaling.
Oncogene. 35:2634–2644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zong CS, Chan J, Levy DE, Horvath C,
Sadowski HB and Wang LH: Mechanism of STAT3 activation by
insulin-like growth factor I receptor. J Biol Chem.
275:15099–15105. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang W, Zong CS, Hermanto U,
Lopez-Bergami P, Ronai Z and Wang LH: RACK1 recruits STAT3
specifically to insulin and insulin-like growth factor 1 receptors
for activation, which is important for regulating
anchorage-independent growth. Mol Cell Biol. 26:413–424. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vandomme J, Touil Y, Ostyn P, Olejnik C,
Flamenco P, El Machhour R, Segard P, Masselot B, Bailliez Y,
Formstecher P and Polakowska R: Insulin-like growth factor 1
receptor and p38 mitogen-activated protein kinase signals inversely
regulate signal transducer and activator of transcription 3
activity to control human dental pulp stem cell quiescence,
propagation, and differentiation. Stem Cells Dev. 23:839–851. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Quelle FW, Thierfelder W, Witthuhn BA,
Tang B, Cohen S and Ihle JN: Phosphorylation and activation of the
DNA binding activity of enriched Stat1 by the Janus
protein-tyrosine kinases and the epidermal growth factor receptor.
J Biol Chem. 270:20775–20780. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shimoda K, Feng J, Murakami H, Nagata S,
Watling D, Rogers NC, Stark GR, Kerr IM and Ihle JN: Jak1 plays an
essential role for receptor phosphorylation and Stat activation in
response to granulocyte colony-stimulating factor. Blood.
90:597–604. 1997.PubMed/NCBI
|
|
43
|
Sawka-Verhelle D, Tartare-Deckert S,
Decaux JF, Girard J and Van Obberghen E: Stat 5B, activated by
insulin in a Jak-independent fashion, plays a role in glucokinase
gene transcription. Endocrinology. 141:1977–1988. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Macha MA, Satyanarayana R, Suprit G, Pai
P, Ponnusamy MP, Batra SK and Jain M: Guggulsterone decreases
proliferation and metastatic behavior of pancreatic cancer cells by
modulating JAK/STAT and Src/FAK signaling. Cancer Lett.
341:166–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kowshik J, Baba AB, Giri H, Reddy Deepak
G, Dixit M and Nagini S: Astaxanthin inhibits JAK/STAT-3 signaling
to abrogate cell proliferation, invasion and angiogenesis in a
hamster model of oral cancer. PLoS One. 9:e1091142014. View Article : Google Scholar : PubMed/NCBI
|
